20973 ⎘
Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans; Cytokines; Lymphokines; Interferons; Interleukins [IL] IL-10
Human lubrication gel
#302Use of members of IL-10 cytokine family
#303Peptides that target dorsal root ganglion neurons
#304Pegylated interleukin-10
#305Compositions and methods for treating organ dysfunction
#306Method to screen for an activator of adipose-resident NK cells
#307Dermal micro-organs, methods and apparatuses for producing and using the same
#308Mesenchymal stem cells and uses therefor
#309Mesenchymal stem cells and uses therefor
#310METHODS FOR TREATING PAIN
#311TREATMENT OF HIV
#312Composition for treating intraventricular hemorrhage in preterm infants comprising mesenchymal stem cells
#313Interleukin-10 peptides and antibodies thereof for inhibiting adverse effects of protozoan infection
#314Combination treatments and compositions for wound healing comprising viral VEGF
#315Use of interleukin 10 mRNA transfected macrophages in anti-inflammatory therapies
#316Immunomodulatory methods and systems for treatment and/or prevention of aneurysms
#317Immunomodulatory methods and systems for treatment and/or prevention of hypertension
#318Sequential administration of a replication defective adenovirus vector in vaccination protocols
#319Human lubrication gel
#320Methods and compositions for delivering interleukin-1 receptor antagonist
#321Immunobinders directed against sclerostin
#322Dermal micro-organs, methods and apparatuses for producing and using the same
#323Dermal micro-organs, methods and apparatuses for producing and using the same
#324Method of treatment of gastrointestinal disorders with IL-10
#325Dermal micro-organs, methods and apparatuses for producing and using the same
#326Medicaments
#327SPHINGOSINE-1-PHOSPHATE RECEPTOR AGONISTS IN THE TREATMENT OF DEMYELINATING DISORDERS
#328TREATMENT OF HIV
#329Dermal micro-organs, methods and apparatuses for producing and using the same
#330Use of Inclusion Bodies as Therapeutic Agents
#331Compositions and methods for modulating an immune response
#332Dermal micro-organs, methods and apparatuses for producing and using the same
#333METHODS AND COMPOSITIONS FOR TREATMENT
#334MHC-Less cells
#335Dermal micro-organs, methods and apparatuses for producing and using the same
#336MESENCHYMAL STEM CELLS AND USES THEREFOR
#337MESENCHYMAL STEM CELLS AND USES THEREFOR
#338Methods of treating ocular and other diseases with Syn-134R polypeptide
#339MESENCHYMAL STEM CELLS AND USES THEREFOR
#340Pegylated interleukin-10
#341Copolymers for suppression of autoimmune diseases, and methods of use
#342Prevention and/or treatment of multiple organ dysfunction syndrome with interleukin-22
#343Mono- and di-PEG IL-10 production; and uses
#344Micronized device for the delivery of biologically active molecules and methods of use thereof
#345CCR7 ligand delivery and co-delivery in immunotherapy
#346B7-H1 and methods of diagnosis, prognosis, and treatment of cancer
#347Peptides that target dorsal root ganglion neurons
#348Compositions and methods for therapeutic delivery with microorganisms
#349Compositions and methods for therapeutic delivery with microorganisms
#350Compositions and methods for therapeutic delivery with microorganisms
#351Compositions and methods for therapeutic delivery with microorganisms
#352Compositions and methods for therapeutic delivery with microorganisms
#353Compositions and methods for therapeutic delivery with microorganisms
#354Mesenchymal Stem Cells and Uses Therefor
#355Method of treating solid cancers with pegylated IL-10
#356LIPOPOLYSACCHARIDE ISOLATED FROM PYRULARIA TISSUE AND/OR PYRULARIA-ASSOCIATED BACTERIA AND USES THEREOF
#357Pegylated Interleukin-10
#358REGULATORY T CELLS IN ADIPOSE TISSUE
#359METHODS AND COMPOSITIONS FOR TEMPORAL RELEASE OF AGENTS FROM A BIODEGRADABLE SCAFFOLD
#360Mesenchymal Stem Cells and Uses Therefor
#361Methods of suppressing microglial activation
#362METHODS AND COMPOSITIONS FOR MODIFYING T CELL IMMUNE RESPONSES AND INFLAMMATION
#363PEGYLATED INTERLEUKIN-10
#364METHODS FOR INHIBITING SCARRING
#365Compositions and methods for preventing cardiac arrhythmia
#366Suppression of immune response to factor VIII in hemophilia A patients
#367Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use
#368Sequential administration of a replication defective adenovirus vector in vaccination protocols
#369Synergism Between Activated Immune Cells and Conventional Cancer Therapies
#370METHODS AND COMPOSITIONS FOR TREATING MUCOSITIS
#371Method of inducing immune tolerance to type I diabetes
#372Multipotent Adult Stem Cells And Uses of Multipotent Adult Stem Cells To Treat Inflammation
#373Dermal micro-organs, methods and apparatuses for producing and using the same
#374Cytokine-based fusion proteins for treatment of multiple sclerosis
#375TOPICAL TREATMENT FOR DISEASES OF EYE SURFACE
#376Use of cytokine-derived peptides in treatment of pain and neurodegenerative disease
#377SPHINGOSINE-1-PHOSPHATE RECEPTOR AGONISTS IN THE TREATMENT OF DEMYELINATING DISORDERS
#378CYSTEINE DIOXYGENASE POLYMORPHISMS
#379Treatment of HIV
#380ILT3 and ILT4-related compositions and methods
#381Therapeutic Agent For Alzheimer's Disease
#382SUPPRESSION OF POSTOPERATIVE ILEUS
#383EXTRACELLULAR TNF INHIBITORS FOR TREATING CNS DISORDERS
#384USE OF PEGYLATED IL-10 TO TREAT CANCER
#385MESENCHYMAL STEM CELLS AND USES THEREFOR
#386Methods of suppressing microglial activation and systemic inflammatory responses
#387Mesenchymal Stem Cells And Uses Therefor
#388METHODS OF SUPPRESSING MICROGLIAL ACTIVATION AND SYSTEMIC INFLAMMATORY RESPONSES
#389Induction of mucosal tolerance to antigens
#390Methods for treating pain
#391Dermal micro-organs, methods and apparatuses for producing and using the same
#392Methods of treating a trauma or disorder of the knee joint by local administration and sustained-delivery of a biological agent
#393CONDITIONED BLOOD COMPOSITION AND METHOD FOR ITS PRODUCTION
#394Mutant IL-10
#395Treatment of depression, psychosis, and anxiety
#396PEGYLATED INTERLEUKIN-10
#397Myeloid Suppressor Cells, Methods For Preparing Them, and Methods For Using Them For Treating Autoimmunity
#398TREATMENT OF GRAFT-VERSUS-HOST DISEASE WITH IL-10 EXPRESSING CELLS
#399TREATMENT OF GRAFT-VERSUS-HOST DISEASE
#4002′,3′-dideoxynucleoside analogues for the treatment or prevention of infections
#401Treatment of Autoimmune Diseases and Allograft Rejection with IL-21
#402Method of treating or preventing tissue deterioration, injury or damage due to a neuro-, muscular- or neuro-muscular-degenerative disease, or restore tissue adversely affected by said disease
#403Anti-T Cell and Autoantigen Treatment of Autoimmune Disease
#404Copolymers for suppression of autoimmune diseases, and methods of use
#405Mesenchymal stem cells and uses therefor
#406Methods of suppressing microglial activation
#407IL-10 Related Peptides For Wound Healing
#408Use of Pegylated IL-10 to Treat Cancer
#409Method for the treatment of automimmune diseases comprising administering rapamycin and IL-10
#410Growth factor for hair and skin treatment
#411Immunomodulating compositions and uses therefor
#412Micronized device for the delivery of biologically active molecules and methods of use thereof
#413Interleukin-10 compositions for the treatment of adenocarcinomas
#414Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use
#415Reduction in myocardial infarction size
#416Compositions and methods involving MDA-7 for the treatment of cancer
#417ULTRAVIOLET THERAPIES FOR SPINE-RELATED PAIN
#418Corneal cells expressing active agents and methods of use thereof
#419Chimeric IL-10
#420Optimizing pharmacodynamics of therapeutic agents for treating vascular tissue
#421Compositions and methods for systemic inhibition of cartilage degradation
#422Pegylated interleukin-10
#423Methods for the treatment of infectious and inflammatory airway diseases
#424Ultra violet therapies for spine-related pain
#425Rapamycin and il-10 for the treatment of immune diseases
#426Prevention and/or treatment of inflammatory bowel disease using pyy or agonists thereof
#427Method of improing the growth performance of an animal
#428Vaccine composition comprising methylated DNA and immunomodulatory motifs
#429B7-H1 and methods of diagnosis, prognosis, and treatment of cancer
#430Organic compounds
#431Anti-osteolytic therapy involving adiponectin
#432Autologous coatings for implants
#433Intradiscal anti-inflammatory therapy involving autologous adiponectin
#434Techniques to treat neurological disorders by enhancing the presence of anti-inflammatory mediators
#435Methods of suppressing microglial activation
#436Methods for treating pain
#437Method for treating inflammatory bowel disease by oral administration of IL-10
#438Self-containing lactobacillus strain
#439Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use
#440Mesenchymal stem cells and uses therefor
#441Immunologic activities of rhesus cytomegalovirus encoded IL-10 and human cytomegalovirus encoded IL-10
#442Extracellular TNF inhibitors for treating CNS disorders
#443Composition and apparatus for transdermal delivery
#444Techniques to treat neurological disorders by attenuating the production of pro-inflammatory mediators
#445Methods and composition for delivering nucleic acids and/or proteins to the intestinal mucosa
#446Chimeric IL-10 proteins and uses thereof
#447Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use
#448Probiotic compositions and methods of use
#449Control of chronic neuropathic pain and allodynia